BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31968117)

  • 21. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting.
    Nyström T; Holzmann MJ; Eliasson B; Kuhl J; Sartipy U
    J Am Coll Cardiol; 2015 Aug; 66(5):535-43. PubMed ID: 26227192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease.
    Kranenburg G; van der Graaf Y; van der Leeuw J; Nathoe HM; de Borst GJ; Kappelle LJ; Visseren FL; Westerink J;
    Diabetes Care; 2015 Oct; 38(10):1930-6. PubMed ID: 26307606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Stress Testing-Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease.
    Garzillo CL; Hueb W; Gersh B; Rezende PC; Lima EG; Favarato D; Franchini Ramires JA; Kalil Filho R
    JAMA Intern Med; 2019 Oct; 179(10):1345-1351. PubMed ID: 31329221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.
    Robich MP; Iribarne A; Leavitt BJ; Malenka DJ; Quinn RD; Olmstead EM; Ross CS; Sawyer DB; Klemperer JD; Clough RA; Kramer RS; Baribeau YR; Sardella GL; DiScipio AW;
    Ann Thorac Surg; 2019 Feb; 107(2):477-484. PubMed ID: 30273572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery.
    Subramaniam B; Lerner A; Novack V; Khabbaz K; Paryente-Wiesmann M; Hess P; Talmor D
    Anesth Analg; 2014 Feb; 118(2):277-287. PubMed ID: 24445629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
    Yang SH; Du Y; Zhang Y; Li XL; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    BMJ Open; 2017 Jun; 7(6):e015041. PubMed ID: 28601829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Glycemic Control Trajectory with Short-Term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study.
    Raghavan S; Liu WG; Berkowitz SA; Barón AE; Plomondon ME; Maddox TM; Reusch JEB; Ho PM; Caplan L
    J Gen Intern Med; 2020 Aug; 35(8):2266-2273. PubMed ID: 32333313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
    Cavender MA; Scirica BM; Raz I; Steg PG; McGuire DK; Leiter LA; Hirshberg B; Davidson J; Cahn A; Mosenzon O; Im K; Braunwald E; Bhatt DL
    Am J Med; 2016 Mar; 129(3):340.e1-8. PubMed ID: 26524706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis.
    Wang J; Luo X; Jin X; Lv M; Li X; Dou J; Zeng J; An P; Chen Y; Chen K; Mu Y
    J Diabetes Res; 2020; 2020():3547491. PubMed ID: 32190696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus.
    Verdoia M; Schaffer A; Cassetti E; Barbieri L; Di Ruocco MV; Perrone-Filardi P; Marino P; De Luca G;
    Am J Prev Med; 2014 Jul; 47(1):9-16. PubMed ID: 24750972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.
    Lee MY; Hsiao PJ; Huang YT; Huang JC; Hsu WH; Chen SC; Shin SJ
    PLoS One; 2017; 12(6):e0178319. PubMed ID: 28591149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemoglobin A
    She J; Deng Y; Wu Y; Xia Y; Li H; Liang X; Shi R; Yuan Z
    Cardiovasc Diabetol; 2017 Aug; 16(1):97. PubMed ID: 28789650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
    Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
    Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Associations of onset age, diabetes duration and glycated hemoglobin level with ischemic stroke risk in type 2 diabetes patients: a prospective cohort study].
    Fan XK; Li MY; Qin Y; Shen C; Lu Y; Sun ZM; Yang J; Tao R; Zhou JY; Hang D; Su J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):498-505. PubMed ID: 38678344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.